2m 2m 2m 2m 2m 2m 2m
ALTO NEURO (ANRO)
NYSE
$28.50+$0.47 (+1.69%)
Price as of Jul 14, 2026 4:55 AM EDT- $929.3MMarket Cap
- 945.90%1-Year Change
- BiotechnologyIndustry
ALTO NEURO (ANRO)
$28.50+$0.47 (+1.69%)
ANRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.03 | ||
Change | +$1.55 (+5.85%) | ||
Open | $26.45 | ||
High | $28.40 | ||
Low | $25.50 | ||
Previous Close | $26.48 | ||
Volume | 2,147,690 | ||
30-Day Average Volume | 764,132 | ||
1-Week Change | 6.90% | ||
1-Month Change | 30.55% | ||
1-Year Change | 945.90% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 35.1M | ||
Total Assets | $276.3M | ||
Market Cap | $929.3M | ||
Enterprise Value | $683.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$26.2M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$25.7M | ||
EBITDA | -$25.6M | ||
Net Working Capital | $256.0M | ||
EPS | -$0.80 | ||
Enterprise Value/EBITDA | -27 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -33 | ||
PEG | 0 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue